•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S04640 Summary:

BILL NOS04640A
 
SAME ASNo Same As
 
SPONSORFERNANDEZ
 
COSPNSR
 
MLTSPNSR
 
Amd §§3309, 3309-b & 3000-a, Pub Health L
 
Authorizes the commissioner of health to establish standards for approval of onsite overdose response services; requires nightlife establishments, sporting or event centers, theaters, concert venues, and amusement parks to maintain a supply of opioid antagonists; provides that emergency use of opioid antagonist is covered by good Samaritan law.
Go to top

S04640 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         4640--A
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                    February 10, 2025
                                       ___________
 
        Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
          printed  to  be committed to the Committee on Alcoholism and Substance
          Use Disorders -- committee discharged, bill amended, ordered reprinted
          as amended and recommitted to said committee
 
        AN ACT to amend the public health law, in relation  to  onsite  overdose
          response  services and requiring certain locations and venues to main-
          tain a supply of opioid antagonists
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivisions  1, 3, 4 and 8 of section 3309 of the public
     2  health law, subdivisions 1 and 3 as amended by chapter 42 of the laws of
     3  2014, subparagraph (iv) of paragraph (a) of subdivision 3  and  subdivi-
     4  sion 4 as amended and subparagraph (v) of paragraph (a) of subdivision 3
     5  as  added by chapter 148 of the laws of 2020, subparagraph (vi) of para-
     6  graph (a) of subdivision 3 and subdivision 8 as added by chapter  83  of
     7  the laws of 2023, and subparagraph (v) of paragraph (b) of subdivision 3
     8  as  added  by  chapter  65  of  the laws of 2016, are amended to read as
     9  follows:
    10    1. The commissioner is authorized to establish standards for  approval
    11  of  any  opioid  overdose  prevention  program, onsite overdose response
    12  services, and opioid antagonist prescribing,  dispensing,  distribution,
    13  possession  and  administration  pursuant  to  this  section  which  may
    14  include, but not be limited to, standards for program directors,  appro-
    15  priate clinical oversight, training, record keeping and reporting.
    16    3. (a) As used in this section:
    17    (i)  "Opioid  antagonist"  means  a drug approved by the Food and Drug
    18  Administration that, when administered, negates or neutralizes in  whole
    19  or in part the pharmacological effects of an opioid in the body. "Opioid
    20  antagonist"  shall be limited to naloxone and other medications approved
    21  by the department for such purpose.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08571-02-5

        S. 4640--A                          2
 
     1    (ii) "Health care professional" means a person licensed, registered or
     2  authorized pursuant to title eight of the  education  law  to  prescribe
     3  prescription drugs.
     4    (iii)  "Pharmacist"  means a person licensed or authorized to practice
     5  pharmacy pursuant to article one hundred thirty-seven of  the  education
     6  law.
     7    (iv)  "Opioid antagonist recipient" [or "recipient"] means a person at
     8  risk of experiencing an opioid-related overdose,  or  a  family  member,
     9  friend  or other person in a position to assist a person experiencing or
    10  at risk of experiencing an opioid-related overdose, or  an  organization
    11  registered  as  an  opioid  overdose prevention program pursuant to this
    12  section or any person or entity or any person employed by the person  or
    13  entity.
    14    (v) As used in this section, "entity" includes, but is not limited to,
    15  a  health  care institution, a not-for-profit charitable organization, a
    16  school  district,  public  library,  board  of  cooperative  educational
    17  services,  county  vocational  education  and  extension  board, charter
    18  school, non-public elementary  or  secondary  school,  restaurant,  bar,
    19  retail store, shopping mall, barber shop, beauty parlor, theater, sport-
    20  ing  or  event  center, inn, hotel [or], motel or public institutions or
    21  buildings.
    22    (vi) "Nightlife establishment" means an establishment that is open  to
    23  the public for entertainment or leisure, serves alcohol or where alcohol
    24  is  consumed on the premises, and conducts a large volume of business at
    25  night. Such term includes, but is not limited  to,  bars,  entertainment
    26  venues, clubs and restaurants.
    27    (vii)  "Onsite  overdose  response  services"  means  the provision of
    28  trained staff who monitor for signs of overdose and respond to suspected
    29  drug overdoses to prevent death and other negative  health  consequences
    30  associated  with drug use, including by administering opioid antagonists
    31  when appropriate.
    32    (b)(i) A health care professional may prescribe by a  patient-specific
    33  or  non-patient-specific  prescription, dispense or distribute, directly
    34  or indirectly, an opioid antagonist to an opioid antagonist recipient.
    35    (ii) A  pharmacist  may  dispense  an  opioid  antagonist,  through  a
    36  patient-specific  or  non-patient-specific prescription pursuant to this
    37  paragraph, to an opioid antagonist recipient.
    38    (iii) An opioid antagonist recipient may possess an opioid  antagonist
    39  obtained  pursuant  to this paragraph, may distribute such opioid antag-
    40  onist to [a] another opioid antagonist  recipient,  and  may  administer
    41  such  opioid  antagonist  to  a  person  the opioid antagonist recipient
    42  reasonably believes is experiencing an opioid overdose.
    43    (iv) The provisions of this paragraph shall not be deemed to require a
    44  prescription for any opioid antagonist that does not otherwise require a
    45  prescription; nor shall it be deemed to limit the authority of a  health
    46  care  professional to prescribe, dispense or distribute, or of a pharma-
    47  cist to dispense, an opioid antagonist under any other provision of law.
    48    (v) Any pharmacy with twenty or more locations  in  the  state,  shall
    49  either:  (1) pursue or maintain a non-patient-specific prescription with
    50  an authorized health care professional to dispense an opioid  antagonist
    51  to a consumer upon request, as authorized by this section; or (2) regis-
    52  ter with the department as an opioid overdose prevention program.
    53    4.  (a)  Use of an opioid antagonist pursuant to this section shall be
    54  considered first aid or emergency treatment for the purpose of any stat-
    55  ute relating to liability.

        S. 4640--A                          3
 
     1    (b) [A] An opioid antagonist recipient, recipient of  onsite  overdose
     2  response  services,  entity providing onsite overdose response services,
     3  opioid overdose prevention program, person  or  entity,  or  any  person
     4  employed by the person or entity, acting reasonably and in good faith in
     5  compliance with this section, shall not be subject to criminal, civil or
     6  administrative liability solely by reason of such action.
     7    8.  The  commissioner  shall  establish guidelines for onsite [opioid]
     8  overdose response [capacity] services, including in nightlife establish-
     9  ments, sporting or event centers, theaters, concert venues,  and  amuse-
    10  ment parks. Such guidelines shall include, but not be limited to:
    11    (a)  maintaining  a supply of unexpired opioid antagonist nasal spray;
    12  and
    13    (b) having employed and at such  location  whenever  in  operation  at
    14  least  two  persons  trained  in  identifying opioid overdoses and using
    15  opioid antagonists.
    16    § 2. Subdivision 2 of section 3309-b of  the  public  health  law,  as
    17  amended  by  chapter  16  of  the  laws  of  2024, is amended to read as
    18  follows:
    19    2. A health care professional,  opioid  overdose  prevention  program,
    20  provider  of onsite overdose response services, or pharmacist is author-
    21  ized to dispense drug adulterant testing supplies to any person.
    22    § 3. Section 3000-a of the public health law, as amended by chapter 69
    23  of the laws of 1994, and subdivision 2 as amended by chapter 373 of  the
    24  laws of 2016, is amended to read as follows:
    25    § 3000-a. Emergency medical treatment. 1. Except as provided in subdi-
    26  vision  six  of section six thousand six hundred eleven, subdivision two
    27  of section six thousand five hundred twenty-seven,  subdivision  one  of
    28  section  six  thousand  nine hundred nine and sections six thousand five
    29  hundred forty-seven and six thousand seven hundred thirty-seven  of  the
    30  education  law,  any  person  who voluntarily and without expectation of
    31  monetary compensation renders first aid or emergency treatment,  includ-
    32  ing  but  not limited to the use of resuscitation equipment that facili-
    33  tates first aid, an automated  external  defibrillator,  an  epinephrine
    34  auto-injector  device, or an opioid antagonist, at the scene of an acci-
    35  dent or other emergency outside a hospital, doctor's office or any other
    36  place having proper and necessary medical equipment, to a person who  is
    37  unconscious,  ill, or injured, shall not be liable for damages for inju-
    38  ries alleged to have been sustained by such person or  for  damages  for
    39  the death of such person alleged to have occurred by reason of an act or
    40  omission  in  the  rendering  of  such  emergency treatment unless it is
    41  established that such injuries were or such death was  caused  by  gross
    42  negligence  on the part of such person. Nothing in this section shall be
    43  deemed or construed to relieve a  licensed  physician,  dentist,  nurse,
    44  physical  therapist  or  registered physician's assistant from liability
    45  for damages for injuries or death caused by an act or  omission  on  the
    46  part  of such person while rendering professional services in the normal
    47  and ordinary course of [his or her] such person's practice.
    48    2. (i) Any person or  entity  that  purchases,  operates,  facilitates
    49  implementation  or  makes available resuscitation equipment that facili-
    50  tates first aid, an automated external defibrillator, an  opioid  antag-
    51  onist, pursuant to section thirty-three hundred nine of this chapter, or
    52  an epinephrine auto-injector device as required by or pursuant to law or
    53  local  law,  or that conducts training under section three thousand-c of
    54  this article, or (ii) an emergency health care provider under a collabo-
    55  rative agreement pursuant to section three thousand-b  of  this  article
    56  with respect to an automated external defibrillator, [or] (iii) a health

        S. 4640--A                          4
 
     1  care  practitioner that prescribes, dispenses or provides an epinephrine
     2  auto-injector device under section three thousand-c of this article,  or
     3  (iv)  a  health care practitioner that prescribes, dispenses or provides
     4  an opioid antagonist shall not be liable for damages arising either from
     5  the use of that equipment by a person who voluntarily and without expec-
     6  tation of monetary compensation renders first aid or emergency treatment
     7  at  the  scene  of  an accident or medical emergency, or from the use of
     8  defectively manufactured equipment; provided that this subdivision shall
     9  not limit the person's or entity's, the emergency  health  care  provid-
    10  er's,  or  other  health  care practitioner's liability for [his, her or
    11  its] such person or entity's own negligence, gross negligence or  inten-
    12  tional misconduct.
    13    § 4. This act shall take effect immediately.
Go to top